Hboc-201: Clinical Trials

1 trial of Hboc-201, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Hboc-201: new trials by email Literature Review of Hboc-201 trials Research Report on Hboc-201

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia
Hemoglobin glutamer 250 - bovine, 6% Hydroxyethylstarch - Peripheral Vascular Disease
Phase 2TerminatedBiopure Corporation162006-05-012008-05-16

Conditions studied

Chronic Limb-Threatening Ischemia (1)  ·  Peripheral Vascular Diseases (1)

Sponsors

Biopure Corporation (1)

Countries

South Africa (1)  ·  United Kingdom (1)

Top investigators

A. Gerson Greenburg, MD, Ph.D. (1)